BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19324938)

  • 1. Inactivation of GSK-3beta by metallothionein prevents diabetes-related changes in cardiac energy metabolism, inflammation, nitrosative damage, and remodeling.
    Wang Y; Feng W; Xue W; Tan Y; Hein DW; Li XK; Cai L
    Diabetes; 2009 Jun; 58(6):1391-402. PubMed ID: 19324938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metallothionein suppresses angiotensin II-induced nicotinamide adenine dinucleotide phosphate oxidase activation, nitrosative stress, apoptosis, and pathological remodeling in the diabetic heart.
    Zhou G; Li X; Hein DW; Xiang X; Marshall JP; Prabhu SD; Cai L
    J Am Coll Cardiol; 2008 Aug; 52(8):655-66. PubMed ID: 18702970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc rescue of Akt2 gene deletion-linked murine cardiac dysfunction and pathological changes is metallothionein-dependent.
    Sun W; Miao X; Zhou S; Zhang L; Epstein PN; Mellen N; Zheng Y; Fu Y; Wang Y; Cai L
    J Mol Cell Cardiol; 2014 Sep; 74():88-97. PubMed ID: 24819347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metallothionein prevents cardiac pathological changes in diabetes by modulating nitration and inactivation of cardiac ATP synthase.
    Cong W; Zhao T; Zhu Z; Huang B; Ma W; Wang Y; Tan Y; Chakrabarti S; Li X; Jin L; Cai L
    J Nutr Biochem; 2014 Apr; 25(4):463-74. PubMed ID: 24629910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metallothionein prevents diabetes-induced cardiac pathological changes, likely via the inhibition of succinyl-CoA:3-ketoacid coenzyme A transferase-1 nitration at Trp(374).
    Cong W; Ma W; Zhao T; Zhu Z; Wang Y; Tan Y; Li X; Jin L; Cai L
    Am J Physiol Endocrinol Metab; 2013 Apr; 304(8):E826-35. PubMed ID: 23423173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation by metallothionein of early cardiac cell death via suppression of mitochondrial oxidative stress results in a prevention of diabetic cardiomyopathy.
    Cai L; Wang Y; Zhou G; Chen T; Song Y; Li X; Kang YJ
    J Am Coll Cardiol; 2006 Oct; 48(8):1688-97. PubMed ID: 17045908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of glycogen synthase kinase 3beta during heart failure is protective.
    Hirotani S; Zhai P; Tomita H; Galeotti J; Marquez JP; Gao S; Hong C; Yatani A; Avila J; Sadoshima J
    Circ Res; 2007 Nov; 101(11):1164-74. PubMed ID: 17901358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes Worsens Ischemia-Reperfusion Brain Injury in Rats Through GSK-3β.
    Liu H; Ou S; Xiao X; Zhu Y; Zhou S
    Am J Med Sci; 2015 Sep; 350(3):204-11. PubMed ID: 26226547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metallothionein Prevents Age-Associated Cardiomyopathy via Inhibiting NF-κB Pathway Activation and Associated Nitrative Damage to 2-OGD.
    Cong W; Niu C; Lv L; Ni M; Ruan D; Chi L; Wang Y; Yu Q; Zhan K; Xuan Y; Wang Y; Tan Y; Wei T; Cai L; Jin L
    Antioxid Redox Signal; 2016 Dec; 25(17):936-952. PubMed ID: 27477335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes- and angiotensin II-induced cardiac endoplasmic reticulum stress and cell death: metallothionein protection.
    Xu J; Wang G; Wang Y; Liu Q; Xu W; Tan Y; Cai L
    J Cell Mol Med; 2009 Aug; 13(8A):1499-512. PubMed ID: 19583814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiac metallothionein synthesis in streptozotocin-induced diabetic mice, and its protection against diabetes-induced cardiac injury.
    Song Y; Wang J; Li Y; Du Y; Arteel GE; Saari JT; Kang YJ; Cai L
    Am J Pathol; 2005 Jul; 167(1):17-26. PubMed ID: 15972948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart.
    Xue W; Liu Y; Zhao J; Cai L; Li X; Feng W
    Am J Physiol Heart Circ Physiol; 2012 Jun; 302(12):H2528-35. PubMed ID: 22523246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
    Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
    Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal improvement by zinc in diabetic mice is associated with glucose metabolism signaling mediated by metallothionein and Akt, but not Akt2.
    Sun W; Wang Y; Miao X; Wang Y; Zhang L; Xin Y; Zheng S; Epstein PN; Fu Y; Cai L
    Free Radic Biol Med; 2014 Mar; 68():22-34. PubMed ID: 24296248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of superoxide generation and associated nitrosative damage is involved in metallothionein prevention of diabetic cardiomyopathy.
    Cai L; Wang J; Li Y; Sun X; Wang L; Zhou Z; Kang YJ
    Diabetes; 2005 Jun; 54(6):1829-37. PubMed ID: 15919806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amelioration of diabetes-induced cognitive deficits by GSK-3β inhibition is attributed to modulation of neurotransmitters and neuroinflammation.
    Datusalia AK; Sharma SS
    Mol Neurobiol; 2014 Oct; 50(2):390-405. PubMed ID: 24420785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic cardiomyopathy - Zinc preventive and therapeutic potentials by its anti-oxidative stress and sensitizing insulin signaling pathways.
    Cai L; Tan Y; Watson S; Wintergerst K
    Toxicol Appl Pharmacol; 2023 Oct; 477():116694. PubMed ID: 37739320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.